Search Results - "Ruffilli B"

308 (PB-124) Poster - Metabolomic profile as a biomarker in early breast cancer patients candidate to neoadjuvant therapy.

Authors: Martini, V. Ruffilli, B. Di Lascio, S. et al.

Source: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.

Authors: Gennari, A. Brain, E. De Censi, A. et al.

Source: Annals of Oncology. Jun2024, Vol. 35 Issue 6, p549-558. 10p.

572P Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intrapatient heterogeneity in ER+/HER2- metastatic breast cancer (MBC) treated with first-line endocrine therapy: Final results of the ET-FES trial.

Authors: Gennari, A. Nardin, S. Brain, E.G.C. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS445-S446. 2p.

339P Transcriptomic profiling of circulating T lymphocytes predicts response to neoadjuvant therapy in patients with early breast cancer.

Authors: Conte, B. D'Alfonso, S. Mellai, M. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS344-S345. 2p.

311P Exploring circulating MDSC role in immune-related adverse events (irAEs) in early triple-negative breast cancer (eTNBC): A preliminary analysis from the IRIS study.

Authors: Taglialatela, I. Negrini, L. Martini, V. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS331-S332. 2p.

384P Axillary surgery management in lobular vs. ductal breast cancer: Real-world insights and clinical implications.

Authors: Matera, L. Conte, B. Caraceni, G. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS363-S363. 1p.

318P PD-L1+ tumoral extracellular vesicles as biomarkers of immune-related toxicities in TNBC: Preliminary results from the IRIS study.

Authors: Landolfo, T.L. Martini, V. Taglialatela, I. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS334-S334. 1p.

316P Blood-based T cell profiling forecast ICI response in early triple-negative breast cancer (eTNBC): Preliminary data from IRIS study.

Authors: Negrini, L. Martini, V. Taglialatela, I. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS333-S333. 1p.

141P Circulating immune cells predict immunotherapy benefit in patients with triple negative breast cancer: Preliminary results from the IRIS study.

Authors: Conte, B. Martini, V. Alsati, R. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS271-S272. 2p.

67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC).

Authors: Cattrini, C. Manfredi, M. Barboro, P. et al.

Source: Annals of Oncology. 2022 Supplement 8, Vol. 33, pS1403-S1404. 2p.

Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management.

Authors: Nardin S Ruffilli B Costantini P et al.

Source: Journal of cardiovascular development and disease [J Cardiovasc Dev Dis] 2025 Jul 16; Vol. 12 (7). Date of Electronic Publication: 2025 Jul 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101651414 Publication Model: Electronic Cited Medium: Internet ISSN: 2308-3425 (Electronic) Linking ISSN: 23083425 NLM ISO Abbreviation: J Cardiovasc Dev Dis Subsets: PubMed not MEDLINE

Updating the Role of Carboplatin Added to Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis.

Authors: Taglialatela I Ruffilli B Conte B et al.

Source: Cancers [Cancers (Basel)] 2025 Dec 12; Vol. 17 (24). Date of Electronic Publication: 2025 Dec 12.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer.

Authors: Fasano M Perri F Pirozzi M et al.

Source: Cancers [Cancers (Basel)] 2025 Nov 02; Vol. 17 (21). Date of Electronic Publication: 2025 Nov 02.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management.

Authors: Nardin S Ruffilli B Landolfo TL et al.

Source: Cancers [Cancers (Basel)] 2025 Aug 22; Vol. 17 (17). Date of Electronic Publication: 2025 Aug 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE